大洋洲 · 新闻 · The Advertiser (Adelaide Now)
Long Shortz Optiscan: FDA submission opens path to US commercialisation
CEO and Managing Director Dr Camile Farah to discuss the company’s US FDA 510(k) submission for its InForm digital pathology device, a major milestone towards potential US…
在 The Advertiser (Adelaide Now) 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.adelaidenow.com.au)


